These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18470946)

  • 21. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
    Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
    J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories.
    Camajova J; Berwouts S; Matthijs G; Macek M; Dequeker E
    Eur J Hum Genet; 2009 Apr; 17(4):537-40. PubMed ID: 19050730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis heterozygotes do not have increased platelet activation.
    Tarnow I; Michelson AD; Frelinger AL; Linden MD; Li Y; Fox ML; Barnard MR; O'Sullivan BP
    Thromb Res; 2007; 121(2):159-62. PubMed ID: 17532368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFTR H609R mutation in Ecuadorian patients with cystic fibrosis.
    Moya-Quiles MR; Glover G; Mondéjar-López P; Pastor-Vivero MD; Fernández-Sánchez A; Sánchez-Solís M
    J Cyst Fibros; 2009 Jul; 8(4):280-1. PubMed ID: 19457724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
    Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
    J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mild cystic fibrosis: genetics - extending follow-up is necessary].
    Gaillard D; Clavel C; Bessaci-Kabouya K; Abély M
    Arch Pediatr; 2009 Apr; 16(4):387-90. PubMed ID: 19181498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of sweat testing: a first report from Italian Cystic Fibrosis Centres.
    Cirilli N; Padoan R; Raia V;
    J Cyst Fibros; 2008 Sep; 7(5):415-22. PubMed ID: 18456576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity.
    Salvatore M; Falbo V; Floridia G; Censi F; Tosto F; Bombieri C; Castaldo G; Pignatti PF; Rosatelli MC; Taruscio D
    Clin Chem Lab Med; 2007; 45(2):254-60. PubMed ID: 17311518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of CFTR gene mutations in Indian CF patients.
    Sharma N; Singh M; Kaur G; Thapa BR; Prasad R
    Ann Hum Genet; 2009 Jan; 73(1):26-33. PubMed ID: 18782298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
    Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
    J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: Still room for improvement.
    Laudus N; Audrézet MP; Girodon E; Morris MA; Radojkovic D; Raynal C; Seia M; Štambergová A; Torkler H; Yamamoto R; Dequeker EMC
    J Cyst Fibros; 2020 Nov; 19(6):969-974. PubMed ID: 32505523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations.
    Kolesár P; Minárik G; Baldovic M; Ficek A; Kovács L; Kádasi L
    Gen Physiol Biophys; 2008 Dec; 27(4):299-305. PubMed ID: 19202204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quality control study of CFTR mutation screening in 40 different European laboratories. The European Concerted Action on Cystic Fibrosis.
    Cuppens H; Cassiman JJ
    Eur J Hum Genet; 1995; 3(4):235-45. PubMed ID: 8528672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CFTR mutation in an Arab patient: clinical and functional features of 875+1G-->A/875+1G-->A genotype.
    Spinelli E; Seia M; Melotti P; Marchina E; Padoan R
    J Cyst Fibros; 2009 Jul; 8(4):282-4. PubMed ID: 19481507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis carrier frequency and estimated prevalence of the disease in Morocco.
    Ratbi I; Génin E; Legendre M; Le Floch A; Costa C; Cherkaoui-Deqqaqi S; Goossens M; Sefiani A; Girodon E
    J Cyst Fibros; 2008 Sep; 7(5):440-3. PubMed ID: 18243066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline sweat test: Utility and limits of genetic analysis for the diagnosis of cystic fibrosis.
    Seia M; Costantino L; Paracchini V; Porcaro L; Capasso P; Coviello D; Corbetta C; Torresani E; Magazzù D; Consalvo V; Monti A; Costantini D; Colombo C
    Clin Biochem; 2009 May; 42(7-8):611-6. PubMed ID: 19318035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease.
    Azad AK; Rauh R; Vermeulen F; Jaspers M; Korbmacher J; Boissier B; Bassinet L; Fichou Y; des Georges M; Stanke F; De Boeck K; Dupont L; Balascáková M; Hjelte L; Lebecque P; Radojkovic D; Castellani C; Schwartz M; Stuhrmann M; Schwarz M; Skalicka V; de Monestrol I; Girodon E; Férec C; Claustres M; Tümmler B; Cassiman JJ; Korbmacher C; Cuppens H
    Hum Mutat; 2009 Jul; 30(7):1093-103. PubMed ID: 19462466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array.
    Lacbawan FL; Weck KE; Kant JA; Feldman GL; Schrijver I;
    Arch Pathol Lab Med; 2012 Jan; 136(1):14-9. PubMed ID: 22208482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.